Takara Bio Inc.
4974.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥99,704 | ¥116,321 | ¥208,679 | ¥269,850 |
| - Cash | ¥29,549 | ¥33,171 | ¥49,058 | ¥22,161 |
| + Debt | ¥1,101 | ¥968 | ¥972 | ¥1,047 |
| Enterprise Value | ¥71,256 | ¥84,118 | ¥160,593 | ¥248,736 |
| Revenue | ¥45,039 | ¥43,505 | ¥78,142 | ¥67,699 |
| % Growth | 3.5% | -44.3% | 15.4% | – |
| Gross Profit | ¥26,067 | ¥26,908 | ¥44,765 | ¥49,211 |
| % Margin | 57.9% | 61.9% | 57.3% | 72.7% |
| EBITDA | ¥6,502 | ¥7,899 | ¥25,983 | ¥31,704 |
| % Margin | 14.4% | 18.2% | 33.3% | 46.8% |
| Net Income | ¥1,042 | ¥1,480 | ¥16,012 | ¥19,849 |
| % Margin | 2.3% | 3.4% | 20.5% | 29.3% |
| EPS Diluted | 8.65 | 12.29 | 132.97 | 164.84 |
| % Growth | -29.6% | -90.8% | -19.3% | – |
| Operating Cash Flow | ¥5,844 | ¥1,711 | ¥36,897 | ¥6,985 |
| Capital Expenditures | -¥9,871 | -¥12,778 | -¥5,882 | -¥12,539 |
| Free Cash Flow | -¥4,027 | -¥11,067 | ¥31,015 | -¥5,554 |